|
Real-time Estimate
Cboe BZX
01:57:02 16/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 23.58 USD | +4.78% |
|
-4.84% | +33.84% |
| 09-24 | Asian Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading | MT |
| 09-04 | Asian Equities Traded in the US as American Depositary Receipts Edge Lower in Friday Trading | MT |
Company Valuation: Zai Lab Limited
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 6,059 | 2,946 | 2,688 | 2,853 | 1,962 | 2,526 | - | - |
| Change | - | -51.37% | -8.77% | 6.15% | -31.23% | 28.75% | - | - |
| Enterprise Value (EV) 1 | 4,650 | 1,938 | 1,897 | 2,095 | 1,397 | 2,068 | 2,145 | 2,289 |
| Change | - | -58.33% | -2.13% | 10.47% | -33.34% | 48.1% | 3.71% | 6.72% |
| P/E | -8.29x | -6.63x | -7.9x | -10.1x | -11x | -10.2x | -10.2x | -15.3x |
| PBR | 4.35x | - | 3.34x | 3.36x | 2.73x | 4.92x | 6.45x | 5.96x |
| PEG | - | 0.2x | 0.3x | 0.4x | 0.3x | -0.3x | -50.64x | 0.5x |
| Capitalization / Revenue | 42x | 13.7x | 10.1x | 7.15x | 4.26x | 5.79x | 4.57x | 3.49x |
| EV / Revenue | 32.2x | 9.01x | 7.11x | 5.25x | 3.04x | 4.74x | 3.89x | 3.16x |
| EV / EBITDA | -6.7x | -4.89x | -5.3x | -7.75x | -6.51x | -7.33x | -9.4x | -18.1x |
| EV / EBIT | -6.64x | -4.79x | -5.17x | -7.43x | -6.09x | -7.27x | -9.31x | -14.6x |
| EV / FCF | -8.19x | -4.94x | -9.23x | -9.5x | -8.5x | -11.4x | -12.1x | -19.5x |
| FCF Yield | -12.2% | -20.2% | -10.8% | -10.5% | -11.8% | -8.78% | -8.3% | -5.14% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -7.58 | -4.63 | -3.46 | -2.6 | -1.6 | -2.209 | -2.214 | -1.47 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 144.3 | 215 | 266.7 | 399 | 460.2 | 436.5 | 552.1 | 723.7 |
| EBITDA 1 | -693.6 | -396.1 | -357.5 | -270.3 | -214.4 | -282.2 | -228.3 | -126.2 |
| EBIT 1 | -700.1 | -404.4 | -366.6 | -282.1 | -229.4 | -284.6 | -230.4 | -156.7 |
| Net income 1 | -704.5 | -443.3 | -334.6 | -257.1 | -175.5 | -240.7 | -211.1 | -157.9 |
| Net Debt 1 | -1,409 | -1,008 | -791.3 | -757.9 | -565.3 | -457.7 | -380.8 | -236.7 |
| Reference price 2 | 62.85 | 30.70 | 27.33 | 26.19 | 17.64 | 22.50 | 22.50 | 22.50 |
| Nbr of stocks (in thousands) | 96,409 | 95,972 | 98,349 | 108,937 | 111,219 | 112,266 | - | - |
| Announcement Date | 1/3/22 | 1/3/23 | 27/2/24 | 27/2/25 | 26/2/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -10.18x | 4.74x | -7.33x | -.--% | 2.53B | |
| 34.58x | 12.46x | 26.12x | 0.57% | 1,077B | |
| 37.53x | 6.26x | 17.55x | 2.1% | 612B | |
| 36.12x | 8.31x | 17.13x | 2.45% | 501B | |
| 113.84x | 6x | 25.7x | 2.32% | 364B | |
| 20.01x | 4.88x | 12.13x | 2.7% | 353B | |
| 20.46x | 5.37x | 13.21x | 2.96% | 278B | |
| 21.15x | 4.27x | 12.26x | 2.07% | 251B | |
| 27.06x | 6.97x | 12.48x | 2.37% | 230B | |
| -44.86x | 6.85x | 26.64x | 2.14% | 190B | |
| Average | 25.57x | 6.61x | 15.59x | 1.97% | 385.9B | |
| Weighted average by Cap. | 35.09x | 7.99x | 19.63x | 1.87% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ZLAB Stock
- Valuation Zai Lab Limited
Select your edition
All financial news and data tailored to specific country editions
